Cita APA

Schlappe, B. A., Mueller, J. J., Zivanovic, O., Gardner, G. J., Roche, K. L., Sonoda, Y., . . . O’Cearbhaill, R. E. (2016). Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center. Gynecol Oncol.

Chicago Style Citation

Schlappe, Brooke A., Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, i Roisin E. O’Cearbhaill. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.

Cita MLA

Schlappe, Brooke A., et al. "Cited Rationale for Variance in the Use of Primary Intraperitoneal Chemotherapy Following Optimal Cytoreduction for Stage III Ovarian Carcinoma At a High Intraperitoneal Chemotherapy Utilization Center." Gynecol Oncol 2016.